
  Mrv0541 02231216062D          

 11 11  0  0  0  0            999 V2000
   -2.5443   -3.5082    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
   -1.8298   -3.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1154   -3.5082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4009   -3.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3136   -3.5082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0280   -3.0957    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7425   -3.5082    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    2.4962   -3.1727    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0482   -3.7858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6357   -4.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8287   -4.3287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
  7 11  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB02308

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium

> <CHEMICAL_FORMULA>
C6H15BNO3

> <MOLECULAR_WEIGHT>
159.999

> <EXACT_MASS>
160.114498817

> <IUPAC_NAME>
2-(4-azaniumylbutoxy)-1,3,2-dioxaborolane

> <IUPAC_TRADITIONAL_NAME>
2-(4-aminiobutoxy)-1,3,2-dioxaborolane

> <INCHI_IDENTIFIER>
InChI=1S/C6H14BNO3/c8-3-1-2-4-9-7-10-5-6-11-7/h1-6,8H2/p+1

> <INCHI_KEY>
InChIKey=KTZDASPSWBAPAR-UHFFFAOYSA-O

> <SMILES>
[NH3+]CCCCOB1OCCO1

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_BASIC_PKA>
10.2

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <ALOGPS_LOGP>
-1.9

> <JCHEM_LOGP>
1.21

> <ALOGPS_LOGS>
-1.3

> <JCHEM_POLARIZABILITY>
18.53

> <JCHEM_POLAR_SURFACE_AREA>
55.33

> <JCHEM_REFRACTIVITY>
47.92

> <JCHEM_ROTATABLE_BOND_COUNT>
5

> <ALOGPS_SOLUBILITY>
9.14e+00 g/l __ 

$$$$
